Fluorodeoxyglucose positron emission tomography

Biomarker

1 paper1 finding

  • Humans1

Associations

1

Amyloid burden

upin humans1

1 study
  1. Fluorodeoxyglucose positron emission tomography predicts amyloid burden in humans (p = 0.008).

    “lower baseline FDG levels were associated with increased PET amyloid burden over time ( p = 0.008)”

    Humanscognitively unimpairedbrain3.3 yearsn = 330

    Cerebral glucose metabolism and regional homogeneity as predictors of amyloid burden changes in preclinical AD

    AAIC 2025 abstractDec 25, 2025

More on Amyloid burden

Latest

Nov 2025: 0Dec 2025: 3Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 1Oct 2026: 06 in 12 months
Research Square

Rare gene variant linked to less decline in brain glucose use

Rare-variant carriers had a 58% smaller age-related reduction in one brain region's glucose use than typical carriers of an inherited Alzheimer's variant.Rare-variant carriers had a 58% smaller age-related reduction in one brain region's glucose use than typical carriers of an inherited Alzheimer's variant.

Preprint: cross-sectional study of 48 peopleMechanisms